Trial intelligence / Profile preview

Adolescent follow-up of neonatal dexamethasone and hydrocortisone exposure in very preterm survivors

NL-OMON33574Active, not recruiting

Sponsor
University Medical Center Utrecht
Start
Apr 2009
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label trial of dexamethasone and hydrocortisone in bronchopulmonary dysplasia (BPD) (3 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Behavioral outcomes during adolescence, Neuropsychological function during adolescence and 14 more. Started Apr 2009; status: active, not recruiting.

02

Drugs

dexamethasonehydrocortisone
03

Conditions

bronchopulmonary dysplasia (BPD)

Beyond the preview

Go deeper on NL-OMON33574.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33574.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call